Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04075604
Title A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer (CheckMate 7A8)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole + Palbociclib

Anastrozole + Nivolumab + Palbociclib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.